A closely-watched lawsuit in the US Supreme Court has reached its conclusion, and sets an important precedent in the battle between brand owners and generic drugmakers over 'skinny' labels for ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...

Earlier this year, Canada became the first major market in the world where generic forms of semaglutide became legal. The competition was on: Manufacturers raced to secure Health Canada approval so ...

Each day, millions of people pick up a prescription drug from their local pharmacy or mailbox. Most are affordable, with co-pays on average less than $7 for 90% of drugs. But for a growing number of ...

Elizabeth Doran, a retired Canadian woman, says she has had to pick up extra teaching shifts to afford her semaglutide medication Elizabeth Doran has been taking GLP-1 medications for nearly a year ...

With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin’s fish oil-derived cardiovascular drug Vascepa does not ...

A unanimous Supreme Court reversed the Federal Circuit and held that Amarin did not plausibly allege that Hikma’s skinny label and marketing actively induced infringement of Vascepa’s ...

The controversial topic of authorized generics has been in the news again recently following a case in which Mylan Pharmaceuticals tried to sue the FDA for approving an authorized generic version of ...

WASHINGTON, June 4 (Reuters) - The U.S. Supreme Court ruled on Thursday drugmaker Hikma's generic version of Amarin Pharma's cardiovascular medication Vascepa did not infringe Amarin's patents, in a ...

Support vector regression can predict numeric values effectively, and this article shows how to implement and train a kernel SVR model in C# using stochastic sub-gradient descent.